Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Bioasis Technologies: A Very BIG Year in Review

It’s been a very busy, big and ambitious year for Bioasis Technologies Inc. ( TSX-V.BTI , OTC:BIOAF , Forum ) – a biopharmaceutical company focused on revolutionizing science by transporting therapeutic payloads across the blood-brain barrier and...
Dave Jackson | December 17, 2020 |

FDA Accepts NDA for Global Blood Therapeutics' Sickle Cell Drug; Shares Up 14%

Shares of Global Blood Therapeutics are trading more than 14% higher after the FDA accepted its New Drug Application filing for Voxelotor, a drug used in the treatment of sickle cell disease. Earlier today clinical-stage biopharmaceutical firm Global Blood Therapeuti...
Streetwise Reports | September 6, 2019 |

Intercept Pharma Shares Rise on FDA Acceptance of NDA for Liver Fibrosis Treatment

Shares of Intercept Pharmaceuticals rose today after the company reported that the U.S. Food and Drug Administration accepted its NDA for obeticholic acid (OCA) for the treatment of liver fibrosis due to NASH and granted priority review status. This morning biopharmac...
Streetwise Reports | November 27, 2019 |

Buzz on the Bullboards: Today’s gainers and tomorrow’s winners

Investors dealt with another rate increase from the U.S. Federal Reserve, but could it be the finale for awhile? Time will tell, but many hope this, the 10th straight rate increase reaching its highest point in 16 years, will be enough to help calm unreasonably high ...
Jonathon Brown | May 4, 2023 |

Monthly Breadth: Dark Clouds Or A Ray Of Hope?

MONTHLY BREADTH - MARCH 2000 Last week’s post looked at a weekly volume-based breadth indicator. With June in the history books, it is a good time to review the message from monthly breadth charts. As shown below, the monthly NYSE Advance-Decline Line peaked in 1998 and thu...
Chris Ciovacco | July 3, 2019 |

A Closer Look at Ximen's Kenville Gold Mine

Established in 1888, the Kenville Gold Mine was British Columbia's first underground operation. Historical records show 65,381 ounces gold produced from 158,842 tonnes milled, for a recovered grade of 12.8 grams per tonne (0.37 ounce per ton) gold. Drilling in the la...
Featured Submission | July 6, 2021 |

Buzz on the Bullboards: Markets underperforming, or is the best yet to come?

So, the “September rally” didn’t really pan out as many indices hit lows not seen in months, but at least interest rates were kept firm for now, so that is some good news, right? Investors have been worried about the possibility o...
Jonathon Brown | September 28, 2023 |

An emerging low in gold stocks?

Gold stocks have been in another recent downtrend, which makes sense during a “wave 2″ correction in gold. If we review the Market Vectors ETF Trust Market Vectors Gold Miners ( NYSE: GDX , Stock Forum ) we can see a possible triple bottom formation. This one though loo...
David Banister | December 11, 2012 |

Review of Massively Successful Tech Puts Trades, and Why the Market Has Probably Hit a Bottom Here

Technical analyst Clive Maund discusses trading activity that took advantage of the market's drop. This article was conceived as a "souvenir article" to assist subscribers who did the trade—and I know from feedback that a significant number of you did—in glo...
Streetwise Reports | March 2, 2020 |

January 2020 in Review: Barometric Bedlam

Back in the 1980s, I had a boss that was right out of Monty Python. A Canadian by birth, he was the son of a very wealthy English nobleman who spent a number of years in Brazil as CEO of Brazilian Traction, where he was raised by servants and nannies and attended private ...
Streetwise Reports | February 4, 2020 |
1 2 3 4 5 6 7 8 9 10 ...